UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005179
Receipt number R000006152
Scientific Title Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab
Date of disclosure of the study information 2011/03/03
Last modified on 2016/03/04 10:50:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab

Acronym

Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab

Scientific Title

Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab

Scientific Title:Acronym

Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab

Region

Japan


Condition

Condition

metastatic colorectal cancer

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Bevacizumab for advanced colorectal cancer refractory to initial chemotherapy was used, Panitumumab to verify the effectiveness of combination therapy as a secondary treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Response Rate:RR

Key secondary outcomes

Safety
Overall survival :OS
Progression free survival :PFS


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

FOLFOX+Panitumumab repeat every 14 days until discontinuance criteria.

Interventions/Control_2

FOLFIRI+Panitumumab repeat every 14 days until discontinuance criteria.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Colorectal cancer histlogical proven
2) Unresectable
3) KRAS wild type
4) Prior treatment was L-OHP-based or CPT-11 based chemotherapy
5) No prior panitumumab/cetuximab
6) More than 20 years old
Expect to survive more than 3 months
ECOG performance status: 0-2
7) Organs (bone marrow, lung, liver, and kidney) failure is not advanced.
i) Neutrophil count: more than 1,500 / mm3
ii)Platelet: more than 100,000 / mm3
iii)Hemoglobin: more than 8.0g/dl
iv)Serum total bilirubin : less than 2.0 mg / dl
v)Serum creatinine : less than 1.5 mg / dl
8) ECG no abnormalities in 28 days before
9) Lesion measured by RECIST in
10) Written patient consent was obtained from patients.

Key exclusion criteria

1) Advanced pleural effusion, ascites
2) CNS metastases
3) Infection
4) Diarrhea (watery stool)
5) Heart disease as a clinical problem
6) Severe complications (intestinal paralysis, intestinal obstruction, interstitial pneumonia or pulmonary fibrosis, it is difficult to control diabetes, heart failure, kidney failure, liver failure etc.)
7) Active double cancer
8) Severe mental disorder
9) Irinotecan, oxaliplatin, panitumumab history of hypersensitivity to
10) Treatment with atazanavir sulfate
11) Pregnant and lacting women
12) Severe drug allergy
13) Judged unfit to by doctors in this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasushi Rino

Organization

Yokohama city university

Division name

Department of surgery

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2645

Email

rino@med.yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Norio Yukawa

Organization

Yokohama city university

Division name

Department of surgery

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2645

Homepage URL


Email

nryukawa@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama city university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 01 Month 07 Day

Date of IRB


Anticipated trial start date

2011 Year 02 Month 01 Day

Last follow-up date

2015 Year 01 Month 01 Day

Date of closure to data entry

2015 Year 01 Month 01 Day

Date trial data considered complete

2015 Year 01 Month 01 Day

Date analysis concluded

2015 Year 01 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 03 Month 03 Day

Last modified on

2016 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006152


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name